There is increasing evidence that the growing rate of chronic diseases in China is related to the transitions that the country is undergoing. This project will review the prevalence of chronic disease in China and make a case for how multinational pharmaceutical companies can position themselves to provide pharmaceutical drugs that prevent or treat chronic diseases. Worldwide chronic diseases, various types of chronic diseases, the risk factors, underlying determinants, and the increasing rate of chronic diseases in China will be discussed. The paper will also analyze China?s healthcare system and give a better understanding of what condition the system is in to serve the needs of the people. A review of the forces within China?s pharmaceutical industry will give a better insight for how multinational pharmaceutical corporations can penetrate into this market and establish operations. Recommendations are also made for how China can reduce chronic diseases via government polices, community based programs, and pharmaceutical interventions.
Research Project (M.B.A.) - Simon Fraser University
Copyright is held by the author(s).
Supervisor or Senior Supervisor
Thesis advisor: Gupta, Sudheer
Member of collection